GLP-1 Use Doubled In Obese Patients And Declined In Diabetics Over Past Decade, Study Suggests

Topline

The use of GLP-1 medications like semaglutide for weight loss has increased twofold over the past decade, but declined in use among type 2 diabetics, according to a new study, and the researchers warn the resulting and ongoing drug shortage may limit diabetics’ access to the drugs.